David is recognised as being one of the 100 powerful advocates for pathology in the global community by the Pathologist magazine in 2018, 2019, 2020 and 2021. Until June 2021 David was leading the NHS England and Improvement Pathology consolidation programme, seeking to deliver efficient, high quality pathology services across England.
During the COVID 19 Pandemic David led NHS England’s laboratory response across the country by managing technology deployment, capacity, funding and workforce to ensure that all capacity requirements were met. The role included advising ministers and healthcare leaders whilst providing policy and strategic direction as a subject matter expert.
In recognition of this work and the work in transforming England’s pathology services, the Royal College of Pathologists awarded David Honorary fellowship of the college in 2020. David was also awarded honorary Doctor of Science by Anglia Ruskin University in recognition of his contribution to the national response during the pandemic. In 2021 David was awarded the CSO’s Lifetime Achievement award again in recognition of his leadership of Pathology services during the Pandemic.
David has a diverse and almost unique experience of providing and leading pathology services to primary, secondary and tertiary care across all pathology disciplines and out into other areas of Healthcare science and diagnostics.
David has previously been an elected IBMS council member for the London Region. David has also represented the IBMS on NICE diagnostic advisory panels, and various national forums including an observer on the Royal College of Pathologist Council and in the Parliamentary and Science committee.
David was appointed Chief Executive of the Institute of Biomedical Science in June 2021 to lead this global professional body representing 21,000 members across 74 countries. Additionally, David was appointed the Scientific Lead for Pathology, for NHS London, in September 2021.